Drug intelligence / Profile preview

Lefukang (Chongqing Searainbow Pharmaceutical)

Development stage
Unknown
Lead developer
Chongqing Searainbow Pharmaceutical
Administration
Oral
01

Overview

Lefukang is a Traditional Chinese Medicine (TCM) capsule developed by Chongqing Searainbow Pharmaceutical for the treatment of chronic pelvic pain resulting from pelvic inflammatory disease (PID). It is specifically indicated for patients presenting with 'Qi stagnation and blood stasis syndrome,' a TCM diagnostic category characterized by persistent lower abdominal pain, distension, and tenderness. The formulation consists of multiple botanical extracts intended to promote blood circulation, resolve stasis, and alleviate pain. Clinical development in China has focused on establishing its efficacy and safety for drug registration as a treatment for the sequelae of PID, with Phase 3 trials conducted to support its regulatory approval.

Brand names
Lefukang
Other names
Lefukang CapsuleLefukang Jiaonang

Beyond the preview

Go deeper on Lefukang (Chongqing Searainbow Pharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lefukang (Chongqing Searainbow Pharmaceutical).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call